SCHEMBL7425754

SCHEMBL7425754

COC(=O)Cc1cccc(O)c1NC(N)=O.c1cc2ccc1-2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFD P00746 1/20 0.40
▸ EGFR P00533 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ GAA P10253 2/20 0.38
▸ GFER P55789 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA7 P43166 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ CA14 Q9ULX7 1/20 0.37
▸ KIF11 P52732 3/20 0.36
▸ GLA P06280 2/20 0.36
▸ NR3C2 P08235 1/20 0.36
▸ ACLY P53396 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ SLC7A5 Q01650 1/20 0.35
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27372885 0.76 TAAR1 (0.37) ALDH1A1GAAGFERKDM4EMAPT
SCHEMBL5281937 0.75 MTNR1A (0.49) ALDH1A1KDM4ENR3C2L3MBTL1
SCHEMBL27479366 0.74 CFD (0.54) CFDALDH1A1GAAKDM4EMAPT
SCHEMBL5273139 0.74 NR3C2 (0.45) ALDH1A1KDM4EMAPTNR3C2L3MBTL1
SCHEMBL25285645 0.74 IAPP (0.51) EGFRALDH1A1GAAGFERKDM4E
SCHEMBL30311288 0.73 AKR1B1 (0.61) EGFRALDH1A1GAAGFERKDM4E
SCHEMBL392976 0.73 AKR1B1 (0.61) EGFRALDH1A1GAAGFERKDM4E
SCHEMBL2981629 0.72 ALDH1A1 (0.50) EGFRALDH1A1GAAGFERKDM4E
Methane SCHEMBL9292057 0.72 AKR1B1 (0.59) EGFRALDH1A1GAAGFERKDM4E
SCHEMBL8147897 0.71 GABRA1 (0.52) CFDEGFRALDH1A1GAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133484-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS AstraZeneca AB (SE) 2001-09-19 — — EP disclosed
WO-2000005223-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITORS ASTRAZENECA AB (SE) 2000-02-03 — — WO disclosed
Send feedback